QuidelOrtho has launched a Certified Analyzer Program, aimed at increasing the availability of diagnostic testing in rural and community hospitals throughout the US. The initiative targets clinics, ...
SAN DIEGO, Aug. 13, 2025 /PRNewswire/ -- QuidelOrtho Corporation (QDEL) has launched a Certified Analyzer Program, an innovative initiative designed to expand access to high-quality diagnostic testing ...
SAN DIEGO, July 14, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho") and BÜHLMANN Laboratories AG today announced the availability of the BÜHLMANN fCAL turbo and fPELA turbo ...
RARITAN, N.J., July 22, 2021 /CNW/ — Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced its VITROS (R) Immunodiagnostic ...
(RTTNews) - Vitro diagnostics company Ortho Clinical Diagnostics (OCDX) announced Tuesday that its VITROS SARS-CoV-2 Antigen Test, designed to detect acute infection, has become the first high-volume ...
- Ortho's new VITROS® Anti-SARS-CoV-2 Total 2 Antibody assay and VITROS® Anti-SARS-CoV-2 IgG 2 Antibody assay receive CE Mark - Both tests can aid in identifying individuals with an adaptive immune ...
Ortho Clinical Diagnostics (NSDQ:OCDX) announced today that its new Vitros SARS-CoV-2 antibody assays received CE Mark approval. Raritan, N.J.-based Ortho Clinical Diagnostics’ Vitros anti-SARS-CoV-2 ...
Copyright 2024 The Associated Press. All Rights Reserved. Share RARITAN, N.J., Sept. 21, 2020 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback